Related references
Note: Only part of the references are listed.A Th17-like developmental process leads to CD8+ Tc17 cells with reduced cytotoxic activity
Magdalena Huber et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
CTLA-4 directly inhibits osteoclast formation
R. Axmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
RANK ligand as a therapeutic target for bone metastases and multiple myeloma
G. David Roodman et al.
CANCER TREATMENT REVIEWS (2008)
High serum YKL-40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients
Anne K. Mylin et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation
Djordje Atanackovic et al.
HAEMATOLOGICA (2008)
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma
I. Breitkreutz et al.
LEUKEMIA (2008)
IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells
Thomas Korn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
TH 17 cells in development:: an updated view of their molecular identity and genetic programming
Chen Dong
NATURE REVIEWS IMMUNOLOGY (2008)
Pathophysiology of myeloma bone disease
Flavia R. Esteve et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity1
Timothy J. Harris et al.
JOURNAL OF IMMUNOLOGY (2007)
IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways
Liang Zhou et al.
NATURE IMMUNOLOGY (2007)
STAT3 regulates cytokine-mediated generation of inflammatory helper T cells
Xuexian O. Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone:: a new type of cancer-host partnership?
T. L. Andersen et al.
JOURNAL OF PATHOLOGY (2007)
Myeloma cells and bone marrow osteoblast interactions: Role in the development of osteolytic lesions in multiple myeloma
Nicola Giuliani et al.
LEUKEMIA & LYMPHOMA (2007)
Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction
Kojiro Sato et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice
Mi-La Cho et al.
JOURNAL OF IMMUNOLOGY (2006)
A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: A potential role in the development of lytic bone disease and tumor progression in multiple myeloma
William G. Gunn et al.
STEM CELLS (2006)
Recent advances in understanding the mechanism of action of bisphosphonates
Fraser P. Coxon et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors
K Noonan et al.
CANCER RESEARCH (2005)
Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals
LH Zou et al.
CANCER RESEARCH (2004)
c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells
W Zou et al.
CANCER RESEARCH (2004)
Bone marrow as a priming site for T-cell responses to blood-borne antigen
M Feuerer et al.
NATURE MEDICINE (2003)
Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes:: a potential role in multiple myeloma bone disease
N Giuliani et al.
BLOOD (2002)
Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor κB ligand
JH Han et al.
BLOOD (2001)
Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow
M Feuerer et al.
NATURE MEDICINE (2001)
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo
DL Lacey et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function
N Udagawa et al.
ENDOCRINOLOGY (2000)
Share Paper
